{固定描述} McKesson Corporation (NYSE: MCK) remains a key holding in Eagle Point Capital's portfolio, with the investment firm’s Spring 2026 update emphasizing the drug distributor’s "cockroach-like" durability. The letter points to McKesson’s core drug distribution network as a mission-critical asset that withstands rapid technological disruption and volatile macroeconomic conditions, including geopolitical conflicts and inflation shocks.
McKesson Corporation (MCK) Core Drug Distribution Network Proves Resilient Amid Macro Uncertainty, Eagle Point Capital Highlights - {财报副标题}
News Analysis
© 2026 Market Analysis. All data is for informational purposes only.